Family Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-16,574
| Closed | -$34K | – | 128 |
|
|
2018
Q3 | $34K | Sell |
16,574
-19,716
| -54% | -$40.4K | 0.02% | 69 |
|
|
2018
Q2 | $65K | Buy |
36,290
+8,572
| +31% | +$15.4K | 0.04% | 71 |
|
|
2018
Q1 | $65K | Sell |
27,718
-9,475
| -25% | -$22.2K | 0.05% | 60 |
|
|
2017
Q4 | $70K | Sell |
37,193
-171,233
| -82% | -$322K | 0.05% | 56 |
|
|
2017
Q3 | $518K | Buy |
208,426
+47,982
| +30% | +$119K | 0.35% | 38 |
|
|
2017
Q2 | $442K | Buy |
160,444
+2,286
| +1% | +$6.3K | 0.3% | 39 |
|
|
2017
Q1 | $477K | Buy |
158,158
+26,713
| +20% | +$80.6K | 0.33% | 37 |
|
|
2016
Q4 | $415K | Buy |
131,445
+32,004
| +32% | +$101K | 0.28% | 42 |
|
|
2016
Q3 | $339K | Sell |
99,441
-7,430
| -7% | -$25.3K | 0.19% | 55 |
|
|
2016
Q2 | $244K | Sell |
106,871
-21,717
| -17% | -$49.6K | 0.14% | 67 |
|
|
2016
Q1 | $323K | Sell |
128,588
-4,606
| -3% | -$11.6K | 0.21% | 48 |
|
|
2015
Q4 | $441K | Sell |
133,194
-8,549
| -6% | -$28.3K | 0.23% | 53 |
|
|
2015
Q3 | $343K | Buy |
141,743
+6,195
| +5% | +$15K | 0.15% | 72 |
|
|
2015
Q2 | $397K | Buy |
135,548
+55,012
| +68% | +$161K | 0.16% | 66 |
|
|
2015
Q1 | $323K | Buy |
+80,536
| New | +$323K | 0.15% | 63 |
|